Skeletal muscle is a major organ of insulin-induced glucose metabolism. In addition, loss of
muscle mass is closely linked to insulin resistance (IR) and metabolic syndrome (Met-S) …

Background Aging is associated with body composition changes that include a reduction of
muscle mass or sarcopenia and an increase in visceral obesity. Thus, aging involves a …

Background Body mass index (BMI) is an inadequate marker of obesity, and cannot
distinguish between fat mass, fat free mass and distribution of adipose tissue. The purpose …

Background & aims There have been several attempts to come up with a global operational
definition of sarcopenia (S), and consequently, a definition of S has been established, to …

Sarcopenic obesity is associated with several negative health outcomes. However, the
prevalence of this condition–and the relationship to physical performance parameters …

Background Myostatin (MSTN) is a key negative regulator of muscle mass in humans and
animals, having direct and indirect influences on molecular regulators of atrophy and …

Obesity is a global epidemic and coupled with the unprecedented growth of the world's older
adult population, a growing number of individuals are both old and obese. Whilst both …

Obesity may aggravate the effects of sarcopenia on skeletal muscle structure and function in
the elderly, but no study has attempted to identify the gene variants associated with …

Introduction Sarcopenia is a muscle disease that is associated with a decline in muscle
strength and function. When this condition coexists with sarcopenia, it is characterized as …

As the proportion of population above age 65 grows, so too increases the prevalence of
those individuals who are obese. This phenomenon of an elderly population with obesity is …